Xvivo Perfusion AB (publ) (STO:XVIVO)
Sweden flag Sweden · Delayed Price · Currency is SEK
235.20
-0.40 (-0.17%)
Jul 24, 2026, 5:29 PM CET

Xvivo Perfusion AB Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
131.5238.56199.9594.5222.316.67
Stock-Based Compensation
-14.416.57---
Other Adjustments
75.97119.15-76.07-9.0127.714.49
Change in Receivables
15.318.79-17.77-25.03-26.86-8.29
Changes in Inventories
32.04-37.94-77.52-33.48-6.33-13.8
Changes in Accounts Payable
2.18-39.5816.1719.2911.02-1.12
Operating Cash Flow
236.35101.07111.2946.2927.86-12.06
Operating Cash Flow Growth
201.06%-9.19%140.44%66.16%--
Capital Expenditures
--93.72-70.73-43.02-18.19-10.19
Sale of Property, Plant & Equipment
-0.20.10.17--
Purchases of Intangible Assets
--159.19-122.42-100.92-112.76-83.88
Cash Acquisitions
--5.63-50.46-17.68-67.45-93.23
Other Investing Activities
--0.07-0.3-0.180.77-0.4
Investing Cash Flow
-249.36-258.41-243.81-161.62-197.62-187.7
Long-Term Debt Issued
-84.23----
Long-Term Debt Repaid
------5.94
Net Long-Term Debt Issued (Repaid)
-84.23----5.94
Issuance of Common Stock
---429.250.45245.35
Net Common Stock Issued (Repurchased)
---429.250.45245.35
Other Financing Activities
--11.98-10.9-10.7-7.29-4.8
Financing Cash Flow
-12.1472.25-10.9418.55-6.84234.61
Effect of Exchange Rate Changes on Cash and Cash Equivalents
7.12---3.6724.469.61
Net Cash Flow
-18.03-85.1-143.43299.54-152.1544.46
Free Cash Flow
236.357.3540.563.279.67-22.25
Free Cash Flow Growth
201.06%-81.89%1139.58%-66.17%--
FCF Margin
26.40%0.90%4.93%0.55%2.33%-8.61%
Free Cash Flow Per Share
7.490.231.280.110.33-0.77
Levered Free Cash Flow
122.78-61.8540.1134.624.94-22.91
Unlevered Free Cash Flow
109.41-113.57-55.99-53.14-8.2-47.74